Gene: COL6A1
Official Full Name: collagen type VI alpha 1 chainprovided by HGNC
Gene Summary: The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10398 | COL6A1 Knockout cell line (HeLa) | Human | COL6A1 | 1:3~1:6 | Negative | Online Inquiry |
KO10399 | COL6A1 Knockout cell line (HCT 116) | Human | COL6A1 | 1:2~1:4 | Negative | Online Inquiry |
KO10400 | COL6A1 Knockout cell line (HEK293) | Human | COL6A1 | 1:3~1:6 | Negative | Online Inquiry |
KO10401 | COL6A1 Knockout cell line (A549) | Human | COL6A1 | 1:3~1:4 | Negative | Online Inquiry |
COL6A1 gene knockout cell lines are specialized cellular models that enable researchers to study the functional role of the COL6A1 gene, a critical component of the extracellular matrix responsible for muscle and connective tissue integrity. These cell lines are engineered to have a targeted deletion of the COL6A1 gene, facilitating investigations into the gene's contribution to various pathophysiological conditions, including muscular dystrophies and other connective tissue disorders. By removing COL6A1 expression, researchers can analyze consequent biological changes in cellular behavior, signaling pathways, and the extracellular matrix organization, enhancing our understanding of these complex diseases.
The mechanism behind these knockout cell lines involves precise gene editing techniques, primarily CRISPR/Cas9 technology, which allows for efficient and specific gene disruption. This targeted approach not only ensures that the COL6A1 gene is effectively inactivated but also minimizes off-target effects, thereby improving the reliability of experimental results. These knockout models serve as valuable tools in both basic and translational research, providing insights into the molecular mechanisms underlying connective tissue diseases and opening avenues for the development of innovative therapeutic interventions.
The scientific importance of COL6A1 gene knockout cell lines extends into various applications, from drug discovery efforts to preclinical studies, enabling researchers to evaluate the efficacy of potential treatments in genetically relevant backgrounds. Compared to traditional cell lines, these knockout models offer a more accurate representation of the disease state, resulting in more predictive preclinical data and enhancing the translational potential of research findings.
The advantages of using COL6A1 gene knockout cell lines include not only their specificity but also their scalability, ease of use, and ability to be utilized across multiple experimental platforms. These attributes make them particularly appealing for researchers and clinicians looking for robust models to generate reproducible and meaningful data.
With our extensive experience in developing cutting-edge biological products, we are dedicated to providing researchers with high-quality COL6A1 gene knockout cell lines that meet the highest standards of scientific rigor. Our commitment to innovation and excellence empowers our users to further their research and advance scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.